BRCA1-associated breast cancers have aggressive pathological traits and are mainly hormone receptor-negative, whereas BRCA2-associated breast cancers have sporadic characteristics and are predominantly hormone receptor-positive [16,20]. This evidence concerns the gene NR4A1 and breast cancer.